Leidos (NYSE: LDOS) will continue to study warfighter performance and operational medicine in support of the Naval Health Research Center under a potential five-year, $82M contract from the Naval Medical Logistics Command.
The company said Monday it will employ a data-driven research modeling approach to augment medical decision tools used by field medical personnel, logisticians and operational commanders.
Leidos will also carry out medical research, development, testing, evaluation and surveillance activities to study warfighter performance under the indefinite-delivery/indefinite-quantity contract.
NMLC aims to help the Department of Defense personnel enhance rehabilitation approaches, warfighter resilience and mission readiness through the contract.
Leidos will conduct most of the work at NHRC in San Diego, California.
Liz Porter, president of Leidos' health group, has assured that NHRC research will be backed by the company's scientific and technical expertise. "We are proud to do our part to improve lives and ensure our military personnel can perform at the highest levels."
NHRC is established to perform studies on military health, infectious diseases and operational readiness. The center also creates logistics, decision support and medical planning tools for the U.S. military.